642
Views
2
CrossRef citations to date
0
Altmetric
Invited Reviews

Evaluating thyroid function in pregnant women

&
Pages 460-479 | Received 15 Dec 2021, Accepted 03 Mar 2022, Published online: 16 Mar 2022

References

  • Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): national health and nutrition examination survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489–499.
  • Jacobson DL, Gange SJ, Rose NR, et al. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol. 1997;84(3):223–243.
  • Rifai N, Horvath AR, Wittwer CT. Tietz textbook of clinical chemistry and molecular diagnostics. 6th ed. St. Louis, Missouri: El Sevier; 2018.
  • Ridgway EC, Longcope C, Maloof F. Metabolic clearance and blood production rates of estradiol in hyperthyroidism. J Clin Endocrinol Metab. 1975;41(3):491–497.
  • Akande EO, Hockaday TD. Plasma oestrogen and luteinizing hormone concentrations in thyrotoxic menstrual disturbance. Proc R Soc Med. 1972;65(9):789–790.
  • Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev. 2010;31(5):702–755.
  • Southren AL, Olivo J, Gordon GG, et al. The conversion of androgens to estrogens in hyperthyroidism. J Clin Endocrinol Metab. 1974;38(2):207–214.
  • Zähringer S, Tomova A, von WK, et al. The influence of hyperthyroidism on the hypothalamic-pituitary-gonadal axis. Exp Clin Endocrinol Diabetes. 2000;108(04):282–289.
  • Akande EO, Hockaday TDR. Plasma luteinizing hormone levels in women with thyrotoxicosis. J Endocrinol. 1972;53(1):173–174.
  • Tanaka T, Tamai H, Kuma K, et al. Gonadotropin response to luteinizing hormone releasing hormone in hyperthyroid patients with menstrual disturbances. Metabolism. 1981;30(4):323–326.
  • Akande EO. The effect of oestrogen on plasma levels of luteinizing hormone in euthyroid and thyrotoxic postmenopausal women. J Obstet Gynaecol Br Commonw. 1974;81(10):795–803.
  • Basedow C. Exophthalmus durch hypertrophie des zellgewebes in der augenhohle. Wchnschr. fd Ges. Heilk. 1840;6:197.
  • Krassas G. The male and female reproductive system in thyrotoxicosis. In: Braverman LE, Utiger RD, editors. Werner and Ingbar’s the thyroid—a fundamental and clinical text. 9th ed. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 621–628.
  • Saxena KM, Crawford JD, Talbot NB. Childhood thyrotoxicosis: a long-term perspective. Br Med J. 1964;2(5418):1153–1158.
  • Wang X, Chen C, Wang L, et al. Conception, early pregnancy loss, and time to clinical pregnancy: a population-based prospective study. Fertil Steril. 2003;79(3):577–584.
  • Gnoth C, Godehardt D, Godehardt E, et al. Time to pregnancy: results of the german prospective study and impact on the management of infertility. Hum Reprod. 2003;18(9):1959–1966.
  • Goldsmith RE, Sturgis SH, Lerman J, et al. The menstrual pattern in thyroid disease. J Clin Endocrinol Metab. 1952;12(7):846–855.
  • Joshi JV, Bhandarkar SD, Chadha M, et al. Menstrual irregularities and lactation failure may precede thyroid dysfunction or goitre. J Postgrad Med. 1993;39:137.
  • Pontikides N, Krassas G. The LH, FSH, PRL and progesterone levels in thyrotoxic female patients before and after treatment. J Endocrinol Invest. 1990;13:164.
  • Poppe K, Glinoer D, Van Steirteghem A, et al. Thyroid dysfunction and autoimmunity in infertile women. Thyroid. 2002;12(11):997–1001.
  • Dhillon-Smith RK, Tobias A, Smith PP, et al. The prevalence of thyroid dysfunction and autoimmunity in women with history of miscarriage or subfertility. J Clin Endocrinol Metab. 2020;105(8):2667–2677.
  • Safa AM, Schumacher OP, Rodriguez-Antunez A. Long-Term follow-up results in children and adolescents treated with radioactive iodine (131I) for hyperthyroidism. N Engl J Med. 1975;292(4):167–171.
  • International commission on radiological Protection-Committee. The evaluation of risks from radiation. Health Phys. 1966;12:239–302.
  • Krassas GE. Thyroid disease and female reproduction. Fertil Steril. 2000;74(6):1063–1070.
  • Tunbridge WMG, Evered DC, Hall R, et al. Lipid profiles and cardiovascular disease in the whickham area with particular reference to thyroid failure. Clin Endocrinol (Oxf)). 1977;7(6):495–508.
  • Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the whickham survey. Clin Endocrinol (Oxf)). 1995;43(1):55–68.
  • Wang C, Crapo LM. The epidemiology of thyroid disease and implications for screening. Endocrinol Metab Clin North Am. 1997;26(1):189–218.
  • Biondi B, Cappola AR, Cooper DS. Subclinical hypothyroidism: a review. JAMA. 2019;322(2):153–160.
  • Redmond GP. Thyroid dysfunction and women’s reproductive health. Thyroid. 2004;14(Suppl 1):5–15.
  • Meikle AW. The interrelationships between thyroid dysfunction and hypogonadism in men and boys. Thyroid. 2004;14 Suppl 1:S17–S25.
  • Longcope C, Abend S, Braverman LE, et al. Androstenedione and estrone dynamics in hypothyroid women. J Clin Endocrinol Metab. 1990;70(4):903–907.
  • Gordon GG, Southren AL. Thyroid - hormone effects on steroid - hormone metabolism. Bull N Y Acad Med. 1977;53(3):241–259.
  • Valenti G, Ceda GP, Denti L, et al. Gonadotropin secretion in hyperthyroidism and hypothyroidism. Ric Clin Lab. 1984;14(1):53–63.
  • Honbo KS, Van Herle AJ, Kellett KA. Serum prolactin levels in untreated primary hypothyroldism. Am J Med. 1978;64(5):782–787.
  • Krassas GE, Pontikides N, Kaltsas T, et al. Disturbances of menstruation in hypothyroidism. Clin Endocrinol (Oxf)). 1999;50(5):655–659.
  • Elbers LPB, Fliers E, Cannegieter SC. The influence of thyroid function on the coagulation system and its clinical consequences. J Thromb Haemost. 2018;16(4):634–645.
  • Ansell J. The blood in the hypothyroidism. Werner ingbars Thyroid - Fundam clincal text. 7th ed. Philadelphia: Lippincott-Raven; 1996. p. 821–825.
  • Benson RC, Dailey ME. The menstrual pattern in hyperthyroidism and subsequent posttherapy hypothyroidism. Surg Gynecol Obstet. 1955;100(1):19–26.
  • Scott JC, Mussey E. Menstrual patterns in myxedema. Am J Obstet Gynecol. 1964;90:161–165.
  • Cramer DW, Sluss PM, Powers RD, et al. Serum prolactin and TSH in an in vitro fertilization population: is there a link between fertilization and thyroid function? J Assist Reprod Genet. 2003;20(6):210–215.
  • van D-DC, van DE, van de VP, et al. More live births in primary subfertile intracytoplasmic sperm Injection-Treated women with high normal TSH levels. Gynecol Obstet Invest. 2021;86:398–407.
  • Bohnet HG, Fiedler K, Leidenberger FA. Subclinical hypothyroidism and infertility. The Lancet. 1981;318(8258):1278.
  • Gerhard I, Becker T, Eggert-Kruse W, et al. Thyroid and ovarian function in infertile women. Hum Reprod. 1991;6(3):338–345.
  • Abalovich M, Mitelberg L, Allami C, et al. Subclinical hypothyroidism and thyroid autoimmunity in women with infertility. Gynecol Endocrinol. 2007;23(5):279–283.
  • Shalev E, Eliyahu S, Ziv M, et al. Routine thyroid function tests in infertile women: Are they necessary? Am J Obstet Gynecol. 1994;171(5):1191–1192.
  • Grassi G, Balsamo A, Ansaldi C, et al. Thyroid autoimmunity and infertility. Gynecol Endocrinol. 2001;15(5):389–396.
  • Arojoki M, Jokimaa V, Juuti A, et al. Hypothyroidism among infertile women in Finland. Gynecol Endocrinol. 2000;14(2):127–131.
  • Venables A, Wong W, Way M, et al. Thyroid autoimmunity and IVF/ICSI outcomes in euthyroid women: a systematic review and Meta-analysis. Reprod Biol Endocrinol. 2020;18(1):120.
  • Raber W, Nowotny P, Vytiska BE, et al. Thyroxine treatment modified in infertile women according to thyroxine‐releasing hormone testing: 5 year follow‐up of 283 women referred after exclusion of absolute causes of infertility. Hum Reprod. 2003;18(4):707–714.
  • Poppe K. MANAGEMENT oF ENDOCRINE DISEASE: Thyroid and female infertility: more questions than answers?!. Eur J Endocrinol. 2021;184(4):R123–R135.
  • Lincoln SR, Ke RW, Kutteh WH. Screening for hypothyroidism in infertile women. J Reprod Med. 1999;44(5):455–457.
  • Calvo RM, Jauniaux E, Gulbis B, et al. Fetal tissues are exposed to biologically relevant free thyroxine concentrations during early phases of development. J Clin Endocrinol Metab. 2002;87(4):1768–1777.
  • Bernal J. Thyroid hormone receptors in brain development and function. Nat Clin Pract Endocrinol Metab. 2007;3(3):249–259.
  • Vulsma T, Gons MH, de Vijlder JJ. Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. N Engl J Med. 1989;321(1):13–16.
  • Cooper DS, Laurberg P. Hyperthyroidism in pregnancy. Lancet Diabetes Endocrinol. 2013;1(3):238–249.
  • Abraham-Nordling M, Byström K, Törring O, et al. Incidence of hyperthyroidism in Sweden. Eur J Endocrinol. 2011;165(6):899–905.
  • Springer D, Zima T, Limanova Z. Reference intervals in evaluation of maternal thyroid function during the first trimester of pregnancy. Eur J Endocrinol. 2009;160(5):791–797.
  • Korevaar TIM, Schalekamp-Timmermans S, de Rijke YB, et al. Hypothyroxinemia and TPO-Antibody positivity are risk factors for premature delivery: the generation R study. J Clin Endocrinol Metab. 2013;98(11):4382–4390.
  • Casey BM, Dashe JS, Wells CE, et al. Subclinical hyperthyroidism and pregnancy outcomes. Obstet Gynecol. 2006;107(2 Pt 1):337–341.
  • Korevaar TIM, Medici M, Visser TJ, et al. Thyroid disease in pregnancy: new insights in diagnosis and clinical management. Nat Rev Endocrinol. 2017;13(10):610–622.
  • Sheffield JS, Cunningham FG. Thyrotoxicosis and heart failure that complicate pregnancy. Am J Obstet Gynecol. 2004;190(1):211–217.
  • Sahu MT, Das V, Mittal S, et al. Overt and subclinical thyroid dysfunction among indian pregnant women and its effect on maternal and fetal outcome. Arch Gynecol Obstet. 2010;281(2):215–220.
  • Luewan S, Chakkabut P, Tongsong T. Outcomes of pregnancy complicated with hyperthyroidism: a cohort study. Arch Gynecol Obstet. 2011;283(2):243–247.
  • Millar LK, Wing DA, Leung AS, et al. Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol. 1994;84(6):946–949.
  • Davis LE, Lucas MJ, Hankins GDV, et al. Thyrotoxicosis complicating pregnancy. Am J Obstet Gynecol. 1989;160(1):63–70.
  • Pillar N, Levy A, Holcberg G, et al. Pregnancy and perinatal outcome in women with hyperthyroidism. Int J Gynecol Obstet. 2010;108(1):61–64.
  • Aggarawal N, Suri V, Singla R, et al. Pregnancy outcome in hyperthyroidism: a case control study. Gynecol Obstet Invest. 2014;77(2):94–99.
  • Männistö T, Mendola P, Grewal J, et al. Thyroid diseases and adverse pregnancy outcomes in a contemporary US cohort. J Clin Endocrinol Metab. 2013;98(7):2725–2733.
  • Andersen S, Laurberg P, Wu C, et al. Attention deficit hyperactivity disorder and autism spectrum disorder in children born to mothers with thyroid dysfunction: a danish nationwide cohort study. BJOG. 2014;121(11):1365–1374.
  • Andersen SL, Olsen J, Wu CS, et al. Low birth weight in children born to mothers with hyperthyroidism and high birth weight in hypothyroidism, whereas preterm birth is common in both conditions: a danish national hospital register study. Eur Thyroid J. 2013;2(2):135–144.
  • Andersen SL, Olsen J, Wu CS, et al. Spontaneous abortion, stillbirth and hyperthyroidism: a danish Population-Based study. Eur Thyroid J. 2014;3(3):164–172.
  • Korevaar TIM, de Rijke YB, Chaker L, et al. Stimulation of thyroid function by human chorionic gonadotropin during pregnancy: a risk factor for thyroid disease and a mechanism for known risk factors. Thyroid. 2017;27(3):440–450.
  • Päkkilä F, Männistö T, Hartikainen A-L, et al. Maternal and Child's Thyroid Function and Child's Intellect and Scholastic Performance. Thyroid. 2015;25(12):1363–1374.
  • Medici M, Korevaar TIM, Schalekamp-Timmermans S, et al. Maternal Early-Pregnancy thyroid function is associated with subsequent hypertensive disorders of pregnancy: the generation R study. J Clin Endocrinol Metab. 2014;99(12):E2591–E2598.
  • Tudela CM, Casey BM, McIntire DD, et al. Relationship of subclinical thyroid disease to the incidence of gestational diabetes. Obstet Gynecol. 2012;119:983–988.
  • Tong Z, Xiaowen Z, Baomin C, et al. The effect of subclinical maternal thyroid dysfunction and autoimmunity on intrauterine growth restriction: a systematic review and Meta-Analysis. Medicine (Baltimore)). 2016;95(19):e3677.
  • Laurberg P, Andersen SL. Antithyroid drug use in pregnancy and birth defects: Why some studies find clear associations, and some studies report none. Thyroid. 2015;25(11):1185–1190.
  • Andersen SL, Olsen J, Wu CS, et al. Birth defects after early pregnancy use of antithyroid drugs: a danish nationwide study. J Clin Endocrinol Metab. 2013;98(11):4373–4381.
  • Nedrebo B, Holm P, Uhlving S, et al. Predictors of outcome and comparison of different drug regimens for the prevention of relapse in patients with graves’ disease. Eur J Endocrinol. 2002;147(5):583–589.
  • Momotani N, Noh J, Oyanagi H, et al. Antithyroid drug therapy for Graves' disease during pregnancy. Optimal regimen for fetal thyroid status. N Engl J Med. 1986;315(1):24–28.
  • Korevaar TIM, Chaker L, Jaddoe VWV, et al. Maternal and birth characteristics are determinants of offspring thyroid function. J Clin Endocrinol Metab. 2016;101(1):206–213.
  • Cooper DS, Rivkees SA. Putting propylthiouracil in perspective. J Clin Endocrinol Metab. 2009;94(6):1881–1882.
  • Takata K, Kubota S, Fukata S, et al. Methimazole-Induced agranulocytosis in patients with graves’ disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily. Thyroid. 2009;19(6):559–563.
  • Taylor PN, Vaidya B. Side effects of anti-Thyroid drugs and their impact on the choice of treatment for thyrotoxicosis in pregnancy. Eur Thyroid J. 2012;1(3):176–185.
  • Laurberg P, Wallin G, Tallstedt L, et al. TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study. Eur J Endocrinol. 2008;158(1):69–75.
  • The American Thyroid Association Taskforce on Thyroid Disease During Pregnancy and Postpartum, Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of the american thyroid association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2011;21(10):1081–1125.
  • Moleti M, Trimarchi F, Vermiglio F. Doubts and concerns about isolated maternal hypothyroxinemia. J Thyroid Res. 2011;2011:463029.
  • Shi X, Han C, Li C, et al. Optimal and safe upper limits of iodine intake for early pregnancy in Iodine-Sufficient regions: a Cross-Sectional study of 7190 pregnant women in China. J Clin Endocrinol Metab. 2015;100(4):1630–1638.
  • Berbel P, Mestre JL, Santamaría A, et al. Delayed neurobehavioral development in children born to pregnant women with mild hypothyroxinemia during the first month of gestation: the importance of early iodine supplementation. Thyroid. 2009;19(5):511–519.
  • Zimmermann MB. The adverse effects of mild-to-Moderate iodine deficiency during pregnancy and childhood: a review. Thyroid. 2007;17(9):829–835.
  • Zimmermann MB, Boelaert K. Iodine deficiency and thyroid disorders. Lancet Diabetes Endocrinol. 2015;3(4):286–295.
  • Pedersen KM, Laurberg P, Iversen E, et al. Amelioration of some pregnancy-associated variations in thyroid function by iodine supplementation. J Clin Endocrinol Metab. 1993;77(4):1078–1083.
  • Negro R, Soldin OP, Obregon M-J, et al. Hypothyroxinemia and pregnancy. Endocr Pract. 2011;17(3):422–429.
  • Knight BA, Shields BM, Hattersley AT, et al. Maternal hypothyroxinaemia in pregnancy is associated with obesity and adverse maternal metabolic parameters. Eur J Endocrinol. 2016;174(1):51–57.
  • Korevaar TIM, Nieboer D, Bisschop PHLT, et al. Risk factors and a clinical prediction model for low maternal thyroid function during early pregnancy: two population-based prospective cohort studies. Clin Endocrinol (Oxf)). 2016;85(6):902–909.
  • Korevaar TIM, Steegers EAP, de Rijke YB, et al. Placental angiogenic factors are associated with maternal thyroid function and modify hCG-Mediated FT 4 stimulation. J Clin Endocrinol Metab. 2015;100(10):E1328–E1334.
  • Yu X, Shan Z, Li C, et al. Iron deficiency, an independent risk factor for isolated hypothyroxinemia in pregnant and nonpregnant women of childbearing age in China. J Clin Endocrinol Metab. 2015;100(4):1594–1601.
  • Benhadi N, Wiersinga WM, Reitsma JB, et al. Ethnic differences in TSH but not in free T4 concentrations or TPO antibodies during pregnancy. Clin Endocrinol (Oxf)). 2007;66(6):765–770.
  • La'ulu SL, Roberts WL. Ethnic differences in First-Trimester thyroid reference intervals. Clin Chem. 2011;57(6):913–915.
  • La’ulu SL, Roberts WL, Visser WE. Second-trimester reference intervals for thyroid tests: the role of ethnicity. Clin Chem. 2007;53(9):1658–1664.
  • Walker JA, Illions EH, Huddleston JF, et al. Racial comparisons of thyroid function and autoimmunity during pregnancy and the postpartum period. Obstet Gynecol. 2005;106(6):1365–1371.
  • Medici M, de Rijke YB, Peeters RP, et al. Maternal early pregnancy and newborn thyroid hormone parameters: the generation R study. J Clin Endocrinol Metab. 2012;97(2):646–652.
  • van den Boogaard E, Vissenberg R, Land JA, et al. Significance of (Sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review. Hum Reprod Update. 2011;17(5):605–619.
  • Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med. 1999;341(8):549–555.
  • Li SW, Chan S-Y. Management of overt hypothyroidism during pregnancy. Best Pract Res Clin Endocrinol Metab. 2020;34(4):101439.
  • Sheehan PM, Nankervis A, Araujo Júnior E, et al. Maternal thyroid disease and preterm birth: Systematic review and Meta-Analysis. J Clin Endocrinol Metab. 2015;100(11):4325–4331.
  • Maraka S, Ospina NMS, O'Keeffe DT, et al. Subclinical hypothyroidism in pregnancy: a systematic review and Meta-Analysis. Thyroid. 2016;26(4):580–590.
  • Negro R, Stagnaro-Green A. Diagnosis and management of subclinical hypothyroidism in pregnancy. BMJ. 2014;349:g4929.
  • Liu H, Shan Z, Li C, et al. Maternal subclinical hypothyroidism, thyroid autoimmunity, and the risk of miscarriage: a prospective cohort study. Thyroid. 2014;24(11):1642–1649.
  • Ying H, Tang Y-P, Bao Y-R, et al. Maternal TSH level and TPOAb status in early pregnancy and their relationship to the risk of gestational diabetes mellitus. Endocrine. 2016;54(3):742–750.
  • Karakosta P, Alegakis D, Georgiou V, et al. Thyroid dysfunction and autoantibodies in early pregnancy are associated with increased risk of gestational diabetes and adverse birth outcomes. J Clin Endocrinol Metab. 2012;97(12):4464–4472.
  • Korevaar TIM, Muetzel R, Medici M, et al. Association of maternal thyroid function during early pregnancy with offspring IQ and brain morphology in childhood: a population-based prospective cohort study. Lancet Diabetes Endocrinol. 2016;4(1):35–43.
  • Henrichs J, Bongers-Schokking JJ, Schenk JJ, et al. Maternal thyroid function during early pregnancy and cognitive functioning in early childhood: the generation R study. J Clin Endocrinol Metab. 2010;95(9):4227–4234.
  • Henrichs J, Ghassabian A, Peeters RP, et al. Maternal hypothyroxinemia and effects on cognitive functioning in childhood: how and why? Clin Endocrinol (Oxf)). 2013;79(2):152–162.
  • Julvez J, Alvarez-Pedrerol M, Rebagliato M, et al. Thyroxine levels during pregnancy in healthy women and early child neurodevelopment. Epidemiology. 2013;24(1):150–157.
  • Casey BM, Dashe JS, Spong CY, et al. Perinatal significance of isolated maternal hypothyroxinemia identified in the first half of pregnancy. Obstet Gynecol. 2007;109(5):1129–1135.
  • Männistö T, Vääräsmäki M, Pouta A, et al. Thyroid dysfunction and autoantibodies during pregnancy as predictive factors of pregnancy complications and maternal morbidity in later life. J Clin Endocrinol Metab. 2010;95(3):1084–1094.
  • Medici M, Timmermans S, Visser W, et al. Maternal thyroid hormone parameters during early pregnancy and birth weight: the generation R study. J Clin Endocrinol Metab. 2013;98(1):59–66.
  • Román GC, Ghassabian A, Bongers-Schokking JJ, et al. Association of gestational maternal hypothyroxinemia and increased autism risk. Ann Neurol. 2013;74(5):733–742.
  • Gyllenberg D, Sourander A, Surcel H-M, et al. Hypothyroxinemia during gestation and offspring schizophrenia in a national birth cohort. Biol Psychiatry. 2016;79(12):962–970.
  • Finken MJJ, van Eijsden M, Loomans EM, et al. Maternal hypothyroxinemia in early pregnancy predicts reduced performance in reaction time tests in 5- to 6-Year-Old offspring. J Clin Endocrinol Metab. 2013;98(4):1417–1426.
  • Modesto T, Tiemeier H, Peeters RP, et al. Maternal mild thyroid hormone insufficiency in early pregnancy and Attention-Deficit/hyperactivity disorder symptoms in children. JAMA Pediatr. 2015;169(9):838–845.
  • Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the american thyroid association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid. 2017;27(3):315–389.
  • Escobar GM, de Obregon MJ, del Rey FE. Role of thyroid hormone during early brain development. Eur J Endocrinol. 2004;151:U25–U37.
  • Calvo R, Obregón MJ, Ruiz de Oña C, et al. Congenital hypothyroidism, as studied in rats. Crucial role of maternal thyroxine but not of 3,5,3'-triiodothyronine in the protection of the fetal brain. J Clin Invest. 1990;86(3):889–899.
  • Maraka S, Mwangi R, McCoy RG, et al. Thyroid hormone treatment among pregnant women with subclinical hypothyroidism: US national assessment. BMJ. 2017;356:i6865.
  • Lazarus JH, Bestwick JP, Channon S, et al. Antenatal thyroid screening and childhood cognitive function. N Engl J Med. 2012;366(6):493–501.
  • Stückle D, Stückle D, Stückle D. Abstracts. Eur Thyroid J. 2016;5:57–176.
  • Muller I, Taylor PN, Daniel RM, et al. CATS II long-term anthropometric and metabolic effects of maternal Sub-optimal thyroid function in offspring and mothers. J Clin Endocrinol Metab. 2020;105(7):dgaa129.
  • Hales C, Taylor PN, Channon S, et al. Controlled antenatal thyroid screening II: Effect of treating maternal suboptimal thyroid function on child behavior. J Clin Endocrinol Metab. 2020;105(3):dgz098.
  • Hales C, Taylor PN, Channon S, et al. Controlled antenatal thyroid screening II: Effect of treating maternal suboptimal thyroid function on child cognition. J Clin Endocrinol Metab. 2018;103(4):1583–1591.
  • Casey BM, Thom EA, Peaceman AM, et al. Treatment of subclinical hypothyroidism or hypothyroxinemia in pregnancy. N Engl J Med. 2017;376(9):815–825.
  • Thyroid disease in pregnancy: ACOG practice bulletin, number 223. Obstet Gynecol. 2020;135:e261.
  • Corrigendum to: Management of thyroid dysfunction during pregnancy and postpartum: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2021;106:e2461.
  • De Groot L, Abalovich M, Alexander EK, et al. Management of thyroid dysfunction during pregnancy and postpartum: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(8):2543–2565.
  • Clinical Practice Guidelines [Internet]. [cited 2021. Dec 4]. Available from: https://www.endocrine.org/clinical-practice-guidelines.
  • Hales CM, Carroll M, Fryan C, et al. Prevalence of obesity and severe obesity among adults: United States, 2017–2018. NCHS Data Brief; 2020. p. 8.
  • Goldman AM, Mestman JH. Transient Non-Autoimmune hyperthyroidism of early pregnancy. J Thyroid Res. 2011;2011:142413.
  • Aagaard-Tillery KM, Silver R, Dalton J. Immunology of normal pregnancy. Semin Fetal Neonatal Med. 2006;11(5):279–295.
  • Rotondi M, Cappelli C, Pirali B, et al. The effect of pregnancy on subsequent relapse from graves’ disease after a successful course of antithyroid drug therapy. J Clin Endocrinol Metab. 2008;93(10):3985–3988.
  • Hamburger JI. Diagnosis and management of Graves' disease in pregnancy. Thyroid. 1992;2(3):219–224.
  • Nakagawa Y, Mori K, Hoshikawa S, et al. Postpartum recurrence of graves’ hyperthyroidism can be prevented by the continuation of antithyroid drugs during pregnancy. Clin Endocrinol (Oxf). 2002;57(4):467–471.
  • Croce L, Di Dalmazi G, Orsolini F, et al. Graves’ disease and the post-partum period: an intriguing relationship. Front Endocrinol (Lausanne)). 2019;10:853.
  • Stagnaro-Green A. Approach to the patient with postpartum thyroiditis. J Clin Endocrinol Metab. 2012;97(2):334–342.
  • Hershman JM. The role of human chorionic gonadotropin as a thyroid stimulator in normal pregnancy. J Clin Endocrinol Metab. 2008;93(9):3305–3306.
  • Geno KA, Reed MS, Cervinski MA, et al. Evaluation of thyroid function in pregnant women using automated immunoassays. Clin Chem. 2021;67(5):772–780.
  • Li C, Shan Z, Mao J, et al. Assessment of thyroid function during first-trimester pregnancy: what is the rational upper limit of serum TSH during the first trimester in chinese pregnant women? J Clin Endocrinol Metab. 2014;99(1):73–79.
  • Hernández JM, Soldevila B, Velasco I, et al. Reference intervals of thyroid function tests assessed by immunoassay and mass spectrometry in healthy pregnant women living in Catalonia. JCM. 2021;10(11):2444.
  • Berghout A, Wiersinga W. Thyroid size and thyroid function during pregnancy: an analysis. Eur J Endocrinol. 1998;138(5):536–542.
  • Gronowski AM. Evaluation of thyroid function during pregnancy: Have We taken a wrong turn? Clin Chem. 2018;64(3):439–441.
  • Moncayo R, Zanon B, Heim K, et al. Thyroid function parameters in normal pregnancies in an iodine sufficient population. BBA Clin. 2015;3:90–95.
  • Cotzias C, Wong S-J, Taylor E, et al. A study to establish gestation-specific reference intervals for thyroid function tests in normal singleton pregnancy. Eur J Obstet Gynecol Reprod Biol. 2008;137(1):61–66.
  • Medici M, Korevaar TIM, Visser WE, et al. Thyroid function in pregnancy: what is normal? Clin Chem. 2015;61(5):704–713.
  • Bunch DR, Firmender K, Harb R, et al. First- and Second-Trimester reference intervals for thyroid function testing in a US population. Am J Clin Pathol. 2021;155(6):776–780.
  • Faix JD, Miller WG. Progress in standardizing and harmonizing thyroid function tests12. Am J Clin Nutr. 2016;104(suppl_3):913S–917S.
  • Thienpont LM, Van Uytfanghe K, Beastall G, IFCC Working Group on Standardization of Thyroid Function Tests, et al. Report of the IFCC working group for standardization of thyroid function tests; part 1: thyroid-stimulating hormone. Clin Chem. 2010;56(6):902–911.
  • Bestwick JP, John R, Maina A, et al. Thyroid stimulating hormone and free thyroxine in pregnancy: expressing concentrations as multiples of the median (MoMs). Clin Chim Acta. 2014;430:33–37.
  • van Deventer HE, Mendu DR, Remaley AT, et al. Inverse log-linear relationship between thyroid-stimulating hormone and free thyroxine measured by direct analog immunoassay and tandem mass spectrometry. Clin Chem. 2011;57(1):122–127.
  • Faix JD. Principles and pitfalls of free hormone measurements. Best Pract Res Clin Endocrinol Metab. 2013;27(5):631–645.
  • Midgley JE. Direct and indirect free thyroxine assay methods: theory and practice. Clin Chem. 2001;47(8):1353–1363.
  • Dhatt GS, Jayasundaram R, Wareth LA, et al. Thyrotrophin and free thyroxine trimester-specific reference intervals in a mixed ethnic pregnant population in the United Arab Emirates. Clin Chim Acta Int J Clin Chem. 2006;370(1-2):147–151.
  • Moon H-W, Chung H-J, Park C-M, et al. Establishment of trimester-specific reference intervals for thyroid hormones in korean pregnant women. Ann Lab Med. 2015;35(2):198–204.
  • Kurioka H, Takahashi K, Miyazaki K. Maternal thyroid function during pregnancy and puerperal period. Endocr J. 2005;52(5):587–591.
  • Fan J-X, Yang S, Qian W, et al. Comparison of the reference intervals used for the evaluation of maternal thyroid function during pregnancy using sequential and nonsequential methods. Chin Med J (Engl). 2016;129(7):785–791.
  • Männistö T, Surcel H-M, Ruokonen A, et al. Early pregnancy reference intervals of thyroid hormone concentrations in a thyroid Antibody-Negative pregnant population. Thyroid. 2011;21(3):291–298.
  • Sun R, Xia J. The reference intervals of thyroid hormones for pregnant women in Zhejiang province. Lab Med. 2017;49(1):5–10.
  • Marwaha RK, Chopra S, Gopalakrishnan S, et al. Establishment of reference range for thyroid hormones in normal pregnant indian women. BJOG Int J Obstet Gynaecol. 2008;115(5):602–606.
  • Lambert-Messerlian G, McClain M, Haddow JE, FaSTER Research Consortium, et al. First- and second-trimester thyroid hormone reference data in pregnant women: a FaSTER (first- and Second-Trimester evaluation of risk for aneuploidy) research consortium study. Am J Obstet Gynecol. 2008;199(1):62.e1–62.e6.
  • Lee RH, Spencer CA, Mestman JH, et al. Free T4 immunoassays are flawed during pregnancy. Am J Obstet Gynecol. 2009;200(3):260.e1-260–e6.
  • Soldin SJ, Soukhova N, Janicic N, et al. The measurement of free thyroxine by isotope dilution tandem mass spectrometry. Clin Chim Acta Int J Clin Chem. 2005;358(1-2):113–118.
  • Fritz KS, Weiss RM, Nelson JC, et al. Unequal concentrations of free T3 and free T4 after ultrafiltration. Clin Chem. 2007;53(7):1384–1385.
  • Anckaert E, Poppe K, Van Uytfanghe K, et al. FT4 immunoassays may display a pattern during pregnancy similar to the equilibrium dialysis ID-LC/tandem MS candidate reference measurement procedure in spite of susceptibility towards binding protein alterations. Clin Chim Acta Int J Clin Chem. 2010;411(17-18):1348–1353.
  • Kahric-Janicic N, Soldin SJ, Soldin OP, et al. Tandem mass spectrometry improves the accuracy of free thyroxine measurements during pregnancy. Thyroid. 2007;17(4):303–311.
  • Yue B, Rockwood AL, Sandrock T, et al. Free thyroid hormones in serum by direct equilibrium dialysis and online solid-phase extraction–liquid chromatography/tandem mass spectrometry. Clin Chem. 2008;54(4):642–651.
  • Wong TK, Pekary AE, Hoo GS, et al. Comparison of methods for measuring free thyroxin in nonthyroidal illness. Clin Chem. 1992;38(5):720–724.
  • Fantz CR, Dagogo-Jack S, Ladenson JH, et al. Thyroid function during pregnancy. Clin Chem. 1999;45(12):2250–2258.
  • Glinoer D, Nayer PD, Bourdoux P, et al. Regulation of maternal thyroid during pregnancy. J Clin Endocrinol Metab. 1990;71(2):276–287.
  • Korevaar TIM, Chaker L, Medici M, et al. Maternal total T4 during the first half of pregnancy: physiologic aspects and the risk of adverse outcomes in comparison with free T4. Clin Endocrinol (Oxf). 2016;85(5):757–763.
  • Karakosta P, Chatzi L, Bagkeris E, et al. First- and Second-Trimester reference intervals for thyroid hormones during pregnancy in “Rhea" Mother-Child Cohort, Crete, Greece”. J Thyroid Res. 2011;2011:490783.
  • Meena M, Chopra S, Jain V, et al. The effect of anti-Thyroid peroxidase antibodies on pregnancy outcomes in euthyroid women. JCDR. 2016;10:QC04–QC07.
  • Citterio CE, Targovnik HM, Arvan P. The role of thyroglobulin in thyroid hormonogenesis. Nat Rev Endocrinol. 2019;15(6):323–338.
  • Rahbari R, Zhang L, Kebebew E. Thyroid cancer gender disparity. Future Oncol. 2010;6(11):1771–1779.
  • del Senno L, Degli Uberti E, Hanau S, et al. In vitro effects of estrogen on tgb and c-myc gene expression in normal and neoplastic human thyroids. Mol Cell Endocrinol. 1989;63(1-2):67–74.
  • Santin AP, Furlanetto TW. Role of estrogen in thyroid function and growth regulation. J Thyroid Res. 2011;2011:875125.
  • Murray JR, Williams GR, Harrington KJ, et al. Rising thyroglobulin tumour marker during pregnancy in a thyroid cancer patient: no cause for alarm? Clin Endocrinol (Oxf)). 2012;77(1):155–157.
  • Leboeuf R, Emerick LE, Martorella AJ, et al. Impact of pregnancy on serum thyroglobulin and detection of recurrent disease shortly after delivery in thyroid cancer survivors. Thyroid. 2007;17(6):543–547.
  • Balucan FS, Morshed SA, Davies TF. Thyroid autoantibodies in pregnancy: their role, regulation and clinical relevance. J Thyroid Res. 2013;2013:182472.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.